Tufts Medical Center to Adopt Molli Surgical Breast Cancer TechTufts Medical Center to Adopt Molli Surgical Breast Cancer Tech

Molli Surgical, a femtech company, today announced its Molli 2 System will be adopted by breast cancer surgeons at Tufts Medical Center in Massachusetts. The technology, which has been lauded as one of the next best things in medtech, was created to replace what the company sees as outdated procedures to mark breast cancer lesions for surgical removal.

“Partnering with the Tufts Medical Center team reflects our shared commitment to creating an exceptional patient experience,” Ananth Ravi, CEO and president of MOLLI Surgical, told MD+DI. “As we look ahead, we’re excited to work with teams like Tufts Medical Center to manifest the future of women’s’ health.”

Image courtesy of Molli Surgical

Molli uses magnetic technology, is wire-free and radiation free, a departure from other localizing procedures commonly used.

“For women who have had doctors identify a lump in the breast and need to go in for a biopsy, usually what she has to do is go to the hospital early in the morning, and have a little metallic wire inserted into the side of her breast where the tip of it is pointing directly at where it needs to be biopsied,” Brittany Barreto, PhD, founder of FemHealth Insights, and host of Femtech focus podcast, told MD+DI in a previous article. “This woman then needs to lay still until her surgical time and it’s not an emergency so sometimes she can be there literally all day with this wire hanging out of her that she can’t move. Molli Surgical is this little tiny bullet that is inserted next to the lump and the women can actually go home and doesn’t even have to stay in the hospital.”

A magnet, roughly the size of a sesame seed and named the Molli Marker, is inserted into the breast to mark the lesion. Surgeons then use the Molli Wand and Molli Tablet to locate the magnet, thus finding the lesion. The technology features directional 3D guidance which enables Molli 2 to direct surgeons to the lesion with millimeter precision, according to the company.

“Our wire-free and radiation-free technology for localizing lesions for breast cancer surgery is a huge improvement from the common modalities thanks to the incorporation of directional 3D guidance technology with millimeter precision,” Ravi said.

Video courtesy of Molli Surgical

The announcement marks the second Tufts Medicine site to incorporate the technology, the first being MelroseWakefield Hospital.

"At Tufts Medical Center, we are always searching for new innovations and technologies to provide an enhanced patient experience that doesn't sacrifice efficiency and accuracy," said Abhishek Chatterjee, MD, chief of the division of plastic surgery at Tufts Medical Center, in the press release. "It's always an added benefit when there is a seamless implementation that makes the transition easy for surgeons, radiologists and the surgical support team."